To the best of our knowledge, we have reported for the first time that interrupting the Vav3 signaling pathway using siRNA induces apoptosis and enhances docetaxel sensitivity through the inhibition of PI3K/Akt, extracellular signal-regulate kinase (ERK), and AR signaling axis in human prostate cancer. This evidence concerns the gene VAV3 and prostate cancer.